Evidence map›Paper›PMID 42177801›Full record

ArticleBiotechnology and bioengineering2026

A Modular Nucleoside Kinase Cascade for the Synthesis of Ribonucleoside Triphosphates.

Oliver T Damm, Martin Pfeiffer, Johannes Zöhrer, Bernd Nidetzky

Abstract read
In one paragraph

Article in Biotechnology and bioengineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Oliver T DammInstitute of Biotechnology and Biochemical Engineering, Graz University of Technology, Graz, Austria.
Martin PfeifferInstitute of Biotechnology and Biochemical Engineering, Graz University of Technology, Graz, Austria.
Johannes ZöhrerInstitute of Biotechnology and Biochemical Engineering, Graz University of Technology, Graz, Austria.
Bernd NidetzkyInstitute of Biotechnology and Biochemical Engineering, Graz University of Technology, Graz, Austria.ORCID https://orcid.org/0000-0002-5030-2643

Funding

This project has partially received funding from FWF Cluster of Excellence COE17, Circular Bioengineering 10.55887/COE17
6 · The paper itself

Abstract

The increasing demand for affordable nucleoside 5'-triphosphates (NTPs) necessitates efficient and scalable methods of synthesis. Herein, we report standardized one-pot enzymatic cascades for the production of all canonical NTPs (ATP, CTP, GTP, UTP). Central to these cascades is the Saccharomyces cerevisiae (Saccharomyces cerevisiae UMP kinase (ScURA6), which efficiently phosphorylates AMP, CMP, and UMP. ScURA6 is inactive toward GMP, so Saccharomyces cerevisiae GMP kinase (ScGMPK) was used to synthesize GTP. NDPs were phosphorylated by Escherichia coli acetate kinase (EcAcK), using acetyl phosphate as the phosphate donor in the presence of catalytic amounts of ATP or GTP. Substrate-specific kinases were used to phosphorylate the nucleoside starting material. The resulting four cascades were optimized for flux through each step to afford the NTP product in the absence of NMP and NDP intermediates. The reactions were intensified for full conversion (≥ 93%) of 50-100 mM substrate within 60-120 min. Alternatively, a modified cascade employing the product NTP as a phosphate shuttle was established, achieving an NTP conversion of ≥ 84%. Preparative-scale syntheses (10 mL) reached up to 89% isolated yield (≥ 150 mg product), demonstrating a robust and scalable platform for NTP production. The kinases used are active with noncanonical nucleosides and nucleoside analogs, offering flexibility for broad synthetic applicability of the cascade transformations used.

Indexed as

PhosphotransferasesRibonucleotidesSaccharomyces cerevisiaeEscherichia coliPhosphotransferasesRibonucleotidesacetyl phosphatemultistep enzymatic cascadenucleoside kinasereaction intensificationribonucleotide triphosphate synthesis

Identifiers

PMID42177801
PMCPMC13397275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.